Rare diseases
Investigational molecules
Locations
Back to Greece174 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of icotrokinra for adults with moderately to severely active Crohn's disease
GreeceTesting zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery
GreeceA Study of Gilteritinib to Eliminate Remaining Cancer Cells in Patients with Acute Myeloid Leukemia and FLT3-ITD Mutation
GreeceA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GreeceA Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes
GreeceA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
GreeceA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
GreeceA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
GreeceA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
GreeceStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
GreeceA study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension
GreeceStudy of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
